ATE240107T1 - Neue verbesserte formulierung zur behandlung der osteoporose - Google Patents

Neue verbesserte formulierung zur behandlung der osteoporose

Info

Publication number
ATE240107T1
ATE240107T1 AT98948029T AT98948029T ATE240107T1 AT E240107 T1 ATE240107 T1 AT E240107T1 AT 98948029 T AT98948029 T AT 98948029T AT 98948029 T AT98948029 T AT 98948029T AT E240107 T1 ATE240107 T1 AT E240107T1
Authority
AT
Austria
Prior art keywords
osteoporosis
treatment
new improved
improved formulation
formulation
Prior art date
Application number
AT98948029T
Other languages
English (en)
Inventor
Anna-Lena Ungell
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE240107T1 publication Critical patent/ATE240107T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT98948029T 1997-10-10 1998-10-05 Neue verbesserte formulierung zur behandlung der osteoporose ATE240107T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9703691A SE9703691D0 (sv) 1997-10-10 1997-10-10 Pharmaceutical compositions
PCT/SE1998/001790 WO1999018972A1 (en) 1997-10-10 1998-10-05 New improved formulation for treatment of osteoporosis

Publications (1)

Publication Number Publication Date
ATE240107T1 true ATE240107T1 (de) 2003-05-15

Family

ID=20408561

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98948029T ATE240107T1 (de) 1997-10-10 1998-10-05 Neue verbesserte formulierung zur behandlung der osteoporose

Country Status (14)

Country Link
US (1) US6372728B1 (de)
EP (2) EP1021194B1 (de)
JP (1) JP2001519398A (de)
AR (1) AR015946A1 (de)
AT (1) ATE240107T1 (de)
AU (1) AU9469198A (de)
DE (1) DE69814656T2 (de)
DK (1) DK1021194T3 (de)
ES (1) ES2200378T3 (de)
PT (1) PT1021194E (de)
SA (1) SA98190775A (de)
SE (1) SE9703691D0 (de)
WO (1) WO1999018972A1 (de)
ZA (1) ZA988886B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1057488A4 (de) * 1998-12-25 2003-10-22 Toray Industries Inhibitoren der interleukin-6 produktion
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) * 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
SI1296689T1 (sl) * 2000-06-20 2006-08-31 Novartis Ag Nacin dajanja pacientu bisfosfonatov
HU228400B1 (en) * 2000-06-20 2013-03-28 Novartis Ag The use of bisphosphonates for treatment of osteoporosis
US6638920B2 (en) * 2000-07-21 2003-10-28 Merck & Co., Inc. Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses
JP4381805B2 (ja) * 2001-07-02 2009-12-09 メリオン リサーチ スリー リミテッド 生物活性材料の送達
AU2003211963A1 (en) 2002-02-14 2003-09-04 Kyukyu Pharmaceutical Co., Ltd. Percutaneous preparations
JP4546704B2 (ja) * 2002-02-14 2010-09-15 救急薬品工業株式会社 経皮投与製剤
CN1939314A (zh) 2002-05-10 2007-04-04 弗·哈夫曼-拉罗切有限公司 用于治疗和预防骨质疏松症的二膦酸
ITMI20032175A1 (it) * 2003-11-11 2005-05-12 Tiberio Bruzzese Formulazioni farmaceutiche di bisfosfonati destinate
US20050182028A1 (en) * 2004-02-13 2005-08-18 Chen Chih-Ming J. Pharmaceutical formulation for oral delivery of bisphosphates
PT2269584T (pt) * 2004-05-24 2022-07-01 Theramex Hq Uk Ltd Forma de dosagem oral entérica sólida de um bisfosfonato contendo um agente quelante
EP1802641B8 (de) * 2004-10-08 2012-03-07 The Board Of Trustees Of The University Of Illinois Bisphosphonatverbindungen und -verfahren für knochenschwundkrankheiten, krebs, knochenschmerzen, immunstörungen und infektionskrankheiten
US8012949B2 (en) * 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
RU2406480C2 (ru) * 2005-04-08 2010-12-20 Озфарма Пти Лтд Трансбуккальная система доставки
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
JP2009530414A (ja) * 2006-03-17 2009-08-27 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ ビスホスホネート化合物及び方法
ES2426445T3 (es) * 2006-04-07 2013-10-23 Merrion Research Iii Limited Forma de dosificación oral sólida que contiene un potenciador
WO2007132714A1 (ja) * 2006-05-16 2007-11-22 The Nisshin Oillio Group, Ltd. 骨密度増加剤
CA2654566A1 (en) * 2006-06-09 2007-12-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
GB0616794D0 (en) 2006-08-24 2006-10-04 Arrow Int Ltd Solid dosage form
US20080139514A1 (en) * 2006-11-29 2008-06-12 Subhash Pandurang Gore Diphosphonic acid pharmaceutical compositions
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
US8974801B2 (en) * 2006-12-21 2015-03-10 Amphastar Pharmaceuticals Inc. Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate
WO2009137080A1 (en) 2008-05-07 2009-11-12 Merrion Research Iii Limited Compositions of gnrh related compounds and processes of preparation
US20100215743A1 (en) * 2009-02-25 2010-08-26 Leonard Thomas W Composition and drug delivery of bisphosphonates
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) * 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
US8802114B2 (en) 2011-01-07 2014-08-12 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
CN105267145B (zh) * 2015-11-01 2019-06-21 袁旭东 双膦酸盐的自乳化配方和相关剂型

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175882C (nl) * 1977-03-28 Procter & Gamble Farmaceutisch preparaat, dat een verbinding met ontstekingtegengaande werking bevat.
GB8618259D0 (en) * 1986-07-25 1986-09-03 Leo Pharm Prod Ltd Pharmaceutical compositions
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
EP0416689B1 (de) * 1989-09-06 1995-11-29 Merck & Co. Inc. Acyloxymethylester der Bisphonsäuren als Knochenresorptions-Inhibitoren
SE9003100D0 (sv) 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
WO1994019003A1 (en) 1993-02-17 1994-09-01 Smithkline Beecham Corporation Microemulsions comprising therapeutic peptides
JP3411690B2 (ja) * 1994-09-21 2003-06-03 帝人株式会社 局所投与用アレンドロン酸ナトリウム製剤
GB9516268D0 (en) * 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon

Also Published As

Publication number Publication date
JP2001519398A (ja) 2001-10-23
EP1310259A2 (de) 2003-05-14
ES2200378T3 (es) 2004-03-01
AU9469198A (en) 1999-05-03
US6372728B1 (en) 2002-04-16
PT1021194E (pt) 2003-09-30
DE69814656T2 (de) 2004-03-25
ZA988886B (en) 1999-04-12
AR015946A1 (es) 2001-05-30
SE9703691D0 (sv) 1997-10-10
EP1021194A1 (de) 2000-07-26
WO1999018972A1 (en) 1999-04-22
EP1021194B1 (de) 2003-05-14
DK1021194T3 (da) 2003-09-01
DE69814656D1 (de) 2003-06-18
EP1310259A3 (de) 2003-05-21
SA98190775A (ar) 2005-12-03

Similar Documents

Publication Publication Date Title
ATE240107T1 (de) Neue verbesserte formulierung zur behandlung der osteoporose
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
ATE259812T1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
ATE179610T1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69924750D1 (de) Gerät zur thermischen behandlung von gewebe
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
FI951856A7 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
DE69905214D1 (de) Mittel zur Behandlung der Osteoporose
DE69834578D1 (de) Verfahren zur behandlung von zementaufschlämmungen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69909208D1 (de) Verfahren zur Herstellung von Alkylhalogensilanen
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69931487D1 (de) Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation
DE69828998D1 (de) Indolderivate verwendbar zur behandlung von u.a. osteoporosis
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60001255D1 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE69811598D1 (de) Verfahren zur Herstellung von Triphendioxazinverbindungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1021194

Country of ref document: EP